Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05909605 · ClinicalTrials.gov registry record
Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 150
- Enrollment target
NCT05909605 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 150 participants.
The verdict
NCT05909605 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently introduced conformal ultrasound sensor offers non-invasive and continuous monitoring of BP, which can potentially improve the quality of patient care, but its accuracy has yet to be thoroughly validated. Here the investigators are working to validate the accuracy of a redesigned ultrasound sensor with enhanced reliability in BP measurements at-home and in clinics even under different interventions.
Interventions
- DEVICE sphygmomanometer
- DEVICE Arterial Line
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2023-12-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05909605
The ClinicalTrials.gov registry entry for NCT05909605 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sphygmomanometer is the first listed.
NCT05909605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05909605 about?
NCT05909605 is a clinical study titled "Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor". Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently i...
What is the current status of trial NCT05909605?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2020-10-20. Estimated completion is 2023-12-02.
What interventions are being tested in trial NCT05909605?
The interventions under investigation include: sphygmomanometer (DEVICE), Arterial Line (DEVICE).
Who is sponsoring clinical trial NCT05909605?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.